Cubist Systematic Strategies’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,920
| Closed | -$222K | – | 1891 |
|
|
2024
Q4 | $222K | Sell |
21,920
-11,162
| -34% | -$113K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $412K | Sell |
33,082
-4,850
| -13% | -$60.4K | ﹤0.01% | 1028 |
|
|
2024
Q2 | $494K | Buy |
+37,932
| New | +$494K | ﹤0.01% | 933 |
|
|
2024
Q1 | – | Sell |
-312
| Closed | -$4.05K | – | 2541 |
|
|
2023
Q4 | $4.05K | Buy |
+312
| New | +$4.05K | ﹤0.01% | 2007 |
|
|
2023
Q3 | – | Sell |
-10,667
| Closed | -$286K | – | 2309 |
|
|
2023
Q2 | $286K | Buy |
+10,667
| New | +$286K | ﹤0.01% | 1563 |
|
|
2023
Q1 | – | Sell |
-32,667
| Closed | -$1.67M | – | 3074 |
|
|
2022
Q4 | $1.67M | Buy |
32,667
+26,776
| +455% | +$1.37M | 0.01% | 1424 |
|
|
2022
Q3 | $482K | Sell |
5,891
-6,808
| -54% | -$557K | ﹤0.01% | 2522 |
|
|
2022
Q2 | $859K | Buy |
12,699
+1,933
| +18% | +$131K | 0.01% | 2214 |
|
|
2022
Q1 | $1.19M | Sell |
10,766
-26,803
| -71% | -$2.96M | 0.01% | 1905 |
|
|
2021
Q4 | $3.62M | Buy |
37,569
+31,169
| +487% | +$3.01M | 0.03% | 869 |
|
|
2021
Q3 | $559K | Buy |
6,400
+3,266
| +104% | +$285K | 0.01% | 1955 |
|
|
2021
Q2 | $485K | Buy |
3,134
+1,135
| +57% | +$176K | 0.01% | 2035 |
|
|
2021
Q1 | $315K | Buy |
+1,999
| New | +$315K | ﹤0.01% | 2224 |
|
|
2020
Q4 | – | Sell |
-5,836
| Closed | -$1.28M | – | 2634 |
|
|
2020
Q3 | $1.28M | Buy |
5,836
+2,692
| +86% | +$590K | 0.02% | 1186 |
|
|
2020
Q2 | $893K | Buy |
3,144
+1,786
| +132% | +$507K | 0.02% | 1246 |
|
|
2020
Q1 | $391K | Sell |
1,358
-3,082
| -69% | -$887K | 0.01% | 1379 |
|
|
2019
Q4 | $1.28M | Buy |
+4,440
| New | +$1.28M | 0.02% | 1006 |
|
|
2019
Q3 | – | Sell |
-5,634
| Closed | -$506K | – | 2337 |
|
|
2019
Q2 | $506K | Buy |
5,634
+4,441
| +372% | +$399K | 0.01% | 1465 |
|
|
2019
Q1 | $105K | Sell |
1,193
-1,289
| -52% | -$113K | ﹤0.01% | 1986 |
|
|
2018
Q4 | $349K | Buy |
2,482
+1,152
| +87% | +$162K | 0.02% | 1177 |
|
|
2018
Q3 | $340K | Buy |
1,330
+753
| +131% | +$192K | 0.02% | 1065 |
|
|
2018
Q2 | $147K | Sell |
577
-1,115
| -66% | -$284K | 0.01% | 1445 |
|
|
2018
Q1 | $341K | Buy |
1,692
+1,628
| +2,544% | +$328K | 0.02% | 1062 |
|
|
2017
Q4 | $9K | Buy |
+64
| New | +$9K | ﹤0.01% | 1855 |
|